WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
CORT
CORCEPT THERAPEUTICS INC
United States
$3.28B104,112,08832.60%67.40%Net BuyingNet Buying
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
United States
$1.92B56,791,86161.46%38.54%Net Selling
HALO
HALOZYME THERAPEUTICS INC
United States
$6.77B127,274,00077.99%22.01%Net SellingNet Selling
CPRX
CATALYST PHARMACEUTICALS INC
United States
$1.96B118,115,07981.35%16.30%Net BuyingNet Buying
EXEL
EXELIXIS INC
United States
$6.52B291,292,70485.75%4.36%Net SellingNet Buying
INCY
INCYTE CORP
United States
$14.29B224,540,75179.14%20.86%Net SellingNet Selling
UTHR
UNITED THERAPEUTICS CORP
United States
$14.26B44,355,69487.63%12.37%Net SellingNet Selling
MDXG
MIMEDX GROUP INC
United States
$1.05B147,603,95543.80%56.20%Net BuyingNet Buying
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
Bermuda
$1.50B70,940,14554.90%9.88%Net SellingNet Selling
ROIV
ROIVANT SCIENCES LTD
Bermuda
$8.38B738,721,80739.48%60.52%Net SellingNet Selling
NVO
NOVO NORDISK A S
Denmark
$640.78B4,510,000,0007.18%0.00%
SRPT
SAREPTA THERAPEUTICS INC
United States
$14.38B94,523,76673.96%26.04%Net BuyingNet Selling
BMRN
BIOMARIN PHARMACEUTICAL INC
United States
$16.14B189,879,80396.22%1.65%Net SellingNet Selling
FENC
FENNEC PHARMACEUTICALS INC
United States
$174.59M27,322,1414.04%95.96%Net SellingNet Selling
TGTX
TG THERAPEUTICS INC
United States
$3.27B154,542,94553.47%46.53%Net SellingNet Selling
RPRX
ROYALTY PHARMA PLC
United States
$15.99B597,437,27151.40%16.58%Net SellingNet Buying
REGN
REGENERON PHARMACEUTICALS INC
United States
$121.21B110,185,50369.55%30.45%Net SellingNet Selling
PBYI
PUMA BIOTECHNOLOGY INC
United States
$173.18M48,238,85057.92%42.08%Net SellingNet Selling
VRTX
VERTEX PHARMACEUTICALS INC
United States
$126.12B258,053,38789.82%1.47%Net SellingNet Selling
PTGX
PROTAGONIST THERAPEUTICS INC
United States
$2.12B58,652,13380.64%19.36%Net SellingNet Selling
GMAB
GENMAB A
Denmark
$17.89B66,122,96472.37%0.00%
LGND
LIGAND PHARMACEUTICALS INC
United States
$1.79B17,963,65315.19%84.81%Net SellingNet Selling
MEIP
MEI PHARMA INC
United States
$19.32M6,662,85716.55%83.45%Net BuyingNet Buying
BNOX
BIONOMICS LIMITED
Australia
$8.66M1,924,808,4440.06%0.33%
OCUP
OCUPHIRE PHARMA INC
United States
$50.94M25,924,1581.12%98.88%Net BuyingNet Buying
KRYS
KRYSTAL BIOTECH INC
United States
$5.80B28,558,44076.38%23.62%Net SellingNet Selling
SPRO
SPERO THERAPEUTICS INC
United States
$76.39M53,986,63925.45%64.29%Net Selling
ORMP
ORAMED PHARMACEUTICALS INC
United States
$102.38M40,628,92412.91%46.37%
GNFT
GENFIT SA
France
$211.80M49,834,9830.15%0.00%
CRSP
CRISPR THERAPEUTICS AG
Switzerland
$4.92B84,918,09363.63%36.37%Net BuyingNet Selling
LPCN
LIPOCINE INC
United States
$41.13M5,347,9405.66%94.34%
VYNE
VYNE THERAPEUTICS INC
United States
$31.09M14,528,24723.04%76.96%Net BuyingNet Buying
TECH
BIO-TECHNE CORP
United States
$12.18B157,584,63797.67%2.33%Net SellingNet Buying
PHAR
PHARMING GROUP NV
Netherlands
$587.86M671,073,2430.00%0.00%
PLX
PROTALIX BIOTHERAPEUTICS INC
Israel
$83.58M73,316,0846.49%93.51%Net Buying
VTGN
VISTAGEN THERAPEUTICS INC
United States
$103.78M27,025,20938.51%61.49%Net BuyingNet Buying
TECX
TECTONIC THERAPEUTIC INC
United States
$63.38M3,741,14644.62%55.38%Net BuyingNet Buying
TRDA
ENTRADA THERAPEUTICS INC
United States
$578.97M33,758,97650.28%49.72%Net BuyingNet Buying
TFFP
TFF PHARMACEUTICALS INC
United States
$6.20M3,098,1343.16%96.84%Net Buying
MIRM
MIRUM PHARMACEUTICALS INC
United States
$1.86B47,133,02150.49%49.51%Net BuyingNet Buying
BGNE
BEIGENE LTD
Cayman Islands
$15.93B1,359,524,3693.42%34.78%Net SellingNet Selling
TARS
TARSUS PHARMACEUTICALS INC
United States
$1.11B37,781,69370.58%29.42%Net SellingNet Selling
JAZZ
JAZZ PHARMACEUTICALS PLC
Ireland
$6.66B63,039,61827.89%72.11%Net SellingNet Selling
KPRX
KIORA PHARMACEUTICALS INC
United States
$12.34M2,917,35547.66%52.34%Net BuyingNet Buying
PRTA
PROTHENA CORP PUBLIC LTD CO
Ireland
$1.21B53,771,84552.98%47.02%Net Buying
OCUL
OCULAR THERAPEUTIX INC
United States
$1.26B154,888,91579.05%20.95%Net BuyingNet Selling
RNA
AVIDITY BIOSCIENCES INC
United States
$4.28B95,636,74884.67%15.33%Net SellingNet Selling
ARGX
ARGENX SE
Belgium
$27.61B59,194,48857.34%0.00%
LEGN
LEGEND BIOTECH CORP
United States
$9.89B363,822,06923.80%0.00%
CALT
CALLIDITAS THERAPEUTICS AB
Sweden
$1.18B59,580,0871.46%0.00%
PRAX
PRAXIS PRECISION MEDICINES INC
United States
$870.45M17,107,88757.14%42.86%Net BuyingNet Buying
KZR
KEZAR LIFE SCIENCES INC
United States
$46.37M72,801,35961.48%21.82%Net Buying
ZLAB
ZAI LAB LTD
China
$1.79B992,087,4304.16%1.97%Net SellingNet Selling
FULC
FULCRUM THERAPEUTICS INC
United States
$497.85M62,153,63863.65%36.35%Net BuyingNet Buying
QSI
QUANTUM-SI INC
United States
$151.74M141,816,48934.87%65.13%Net BuyingNet Selling
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
United States
$623.74M26,931,82688.04%11.96%Net SellingNet Selling
ACAD
ACADIA PHARMACEUTICALS INC
United States
$2.94B165,220,88471.24%28.76%Net SellingNet Selling
SGMT
SAGIMET BIOSCIENCES INC
United States
$106.27M31,913,88751.04%48.96%Net Buying
JANX
JANUX THERAPEUTICS INC
United States
$2.29B51,850,66750.08%49.92%Net SellingNet Selling
VRDN
VIRIDIAN THERAPEUTICS INC
United States
$886.49M63,822,46870.96%29.04%Net Buying
AUPH
AURINIA PHARMACEUTICALS INC
Canada
$802.34M143,019,36538.39%3.20%Net SellingNet Selling
ACIU
AC IMMUNE SA
Switzerland
$361.08M99,197,82929.20%0.00%
BRTX
BIORESTORATIVE THERAPIES INC
United States
$11.85M6,769,9190.38%99.62%Net Buying
ARDX
ARDELYX INC
United States
$1.38B233,976,57238.74%61.26%Net SellingNet Selling
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
Israel
$57.27M11,454,51212.36%0.00%
AGIO
AGIOS PHARMACEUTICALS INC
United States
$2.60B56,772,96675.58%24.42%Net SellingNet Selling
ZYME
ZYMEWORKS INC
Canada
$712.00M70,704,89062.27%37.73%Net Selling
INO
INOVIO PHARMACEUTICALS INC
United States
$293.05M25,910,70111.58%88.42%Net SellingNet Selling
SXTP
60 DEGREES PHARMACEUTICALS INC
United States
$2.97M12,142,1164.00%32.90%Net BuyingNet Buying
VNDA
VANDA PHARMACEUTICALS INC
United States
$344.53M58,198,27354.83%45.17%Net Selling
XBIO
XENETIC BIOSCIENCES INC
United States
$6.29M1,540,6840.48%99.52%
TTNP
TITAN PHARMACEUTICALS INC
United States
$4.05M914,2340.08%99.92%
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
United States
$4.84M1,348,1267.87%3.96%
MNKD
MANNKIND CORP
United States
$1.55B272,315,84630.11%69.89%Net SellingNet Selling
ATYR
ATYR PHARMA INC
United States
$120.08M69,010,94060.58%22.26%Net BuyingNet Buying
DNTH
DIANTHUS THERAPEUTICS INC
United States
$849.67M29,349,46945.66%54.34%Net Buying
QURE
UNIQURE NV
Netherlands
$423.35M48,549,43766.45%13.84%Net SellingNet Selling
ADAG
ADAGENE INC
China
$121.76M55,145,83922.30%0.00%
IVVD
INVIVYD INC
United States
$141.99M119,315,78744.12%55.88%Net SellingNet Selling
GERN
GERON CORP
United States
$2.79B593,132,54073.16%1.22%Net BuyingNet Buying
IMCR
IMMUNOCORE HOLDINGS PLC
United Kingdom
$1.98B50,011,61082.37%2.88%Net Buying
DBVT
DBV TECHNOLOGIES SA
France
$77.15M96,434,36939.08%15.37%Net BuyingNet Selling
AUTL
AUTOLUS THERAPEUTICS PLC
United Kingdom
$1.13B266,036,12865.86%0.00%
ADMA
ADMA BIOLOGICS INC
United States
$2.96B231,809,19775.24%24.08%Net SellingNet Selling
ALT
ALTIMMUNE INC
United States
$560.13M70,902,19141.28%58.72%Net Selling
ZVRA
ZEVRA THERAPEUTICS INC
United States
$244.84M41,853,49433.24%28.88%Net Buying
CTMX
CYTOMX THERAPEUTICS INC
United States
$110.65M77,919,36956.85%26.87%Net Buying
HOWL
WEREWOLF THERAPEUTICS INC
United States
$116.89M43,455,36751.91%48.09%
LEXX
LEXARIA BIOSCIENCE CORP
Canada
$44.11M15,810,2055.62%3.92%Net BuyingNet Buying
BRNS
BARINTHUS BIOTHERAPEUTICS PLC
United Kingdom
$58.94M39,033,15824.85%54.22%
FATE
FATE THERAPEUTICS INC
United States
$410.93M113,831,96967.68%32.32%Net Selling
SPRY
ARS PHARMACEUTICALS INC
United States
$1.10B96,895,25642.92%57.08%Net BuyingNet Selling
GTHX
G1 THERAPEUTICS INC
United States
$166.78M52,281,39127.36%47.46%Net SellingNet Selling
GLYC
GLYCOMIMETICS INC
United States
$18.57M64,464,41236.53%63.47%Net BuyingNet Buying
VALN
VALNEVA SE
$527.17M138,912,1420.32%0.00%
LQDA
LIQUIDIA CORP
United States
$963.19M76,382,71839.64%60.36%Net BuyingNet Selling
IDYA
IDEAYA BIOSCIENCES INC
United States
$3.03B75,686,62891.30%8.70%Net BuyingNet Buying
CRNX
CRINETICS PHARMACEUTICALS INC
United States
$4.23B78,859,51086.57%13.43%Net BuyingNet Buying
RYTM
RHYTHM PHARMACEUTICALS INC
United States
$3.05B60,972,90988.14%11.86%Net SellingNet Buying
ZNTL
ZENTALIS PHARMACEUTICALS INC
United States
$281.92M71,013,23374.37%25.63%Net SellingNet Selling

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jul 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 73, which is 50 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 38.71% over the past year, overperforming other biotech stocks by 50 percentage points.

Corcept Therapeutics has an average 1 year price target of $46.67, an upside of 48.15% from Corcept Therapeutics's current stock price of $31.50.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 68, which is 45 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -2.29% over the past year, overperforming other biotech stocks by 9 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $47.25, an upside of 40% from Harmony Biosciences Holdings's current stock price of $33.75.

Harmony Biosciences Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Harmony Biosciences Holdings, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Halozyme Therapeutics (NASDAQ:HALO)


Halozyme Therapeutics (NASDAQ:HALO) is the third best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 22 out of 33 due diligence checks and has strong fundamentals. Halozyme Therapeutics has seen its stock return 43% over the past year, overperforming other biotech stocks by 55 percentage points.

Halozyme Therapeutics has an average 1 year price target of $57.00, an upside of 7.18% from Halozyme Therapeutics's current stock price of $53.18.

Halozyme Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Halozyme Therapeutics, 28.57% have issued a Strong Buy rating, 42.86% have issued a Buy, 28.57% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 2 biotech stocks that have issued dividends in the past year, the 2 biotech stocks with the highest dividend yields are:

1. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 0.97%, which is the same as the biotech industry average of 0.72%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

2. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.41%, which is the same as the biotech industry average of 0.72%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 25.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.32% in the last day, and up 8.61% over the last week. Immutep was the among the top gainers in the biotechnology industry, gaining 14.93% yesterday.

Immutep shares are trading higher after the company announced results from Cohort B of the TACTI-003 Phase IIb trial evaluating eftilagimod alfa in combination with MSD's anti-PD-1 therapy KEYTRUDA as first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma patients with negative PD-L1 expression.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -14.42% in the past year. It has underperformed other stocks in the biotech industry by -3 percentage points.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has gained 1.61% in the past year. It has overperformed other stocks in the biotech industry by 13 percentage points.

3. Bionomics Limited (NASDAQ:BNOX)


Bionomics Limited (NASDAQ:BNOX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Bionomics Limited has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Bionomics Limited's stock has dropped -70.59% in the past year. It has underperformed other stocks in the biotech industry by -59 percentage points.

Are biotech stocks a good buy now?

53.24% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 73.96% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -12.81x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.